Quick answer
When a company provides an interest-free or subsidised loan to an individual in that person’s capacity as a director, “no interest paid” does not mean there is no employment-tax benefit. IRAS treats the resulting interest benefit as a taxable employment benefit.
For October to December 2026, the IRAS rate used to compute the benefit is 2.6% a year. The rate was also 2.6% for April to September 2026, so this is a current-quarter reminder rather than a new rate cut.
Gross monthly benefit = month-end outstanding loan balance × applicable annual rate × 1/12
For a subsidised loan, deduct the interest payable by the director from that gross amount. If the director’s interest exceeds the gross amount, seek advice rather than assuming the calculation creates a negative taxable benefit.
This guide explains the employment-tax computation only. It does not decide whether the company is permitted to make the loan, what corporate approvals are required, or how a particular director should be taxed after considering all personal facts.
Source note: IRAS, “Benefits Relating to Loans”, last updated 23 September 2026 and accessed 5 October 2026.
What IRAS taxes
The taxable item is the interest benefit received in the person’s capacity as a company director. IRAS treats company directors as employees for this purpose and states that these loan benefits are taxable as employment benefits.
Capacity matters where the same person is both a director and shareholder. IRAS guidance says a bona fide loan made solely in shareholder capacity may fall outside the employment-benefit treatment, but that conclusion depends on the facts and contemporaneous evidence. It is not a blanket shareholder exemption and this article does not determine that capacity for any transaction.
This is different from simply recording the cash advanced as an amount due from the director in the company’s accounts. The loan balance and the taxable interest benefit are separate figures and should not be combined in one unexplained ledger entry.
If the company later waives part or all of the principal, the IRAS summary table states that the amount waived is taxable. A waiver should therefore be reviewed separately from the recurring interest-benefit calculation.
Which rate applies in late 2026
From 1 April 2023, IRAS says the computation rate is 1.5 percentage points above the applicable three-month compounded Singapore Overnight Rate Average published on 1 March and 1 September each year. The 1 March reference feeds the April–September period; the 1 September reference feeds the October–March period. Use the rate IRAS publishes for the relevant period rather than forecasting it from SORA.
| Period | Annual rate used for the interest benefit |
|---|---|
| January–March 2026 | 3.0% |
| April–September 2026 | 2.6% |
| October–December 2026 | 2.6% |
| January–March 2027 | 2.6% |
Do not use one rate for the whole year simply because the loan remained outstanding. Apply the rate for each period to the relevant month-end balance.
A simple calculation
Assume the director owes the company S$100,000 at the end of October, November and December 2026, and the loan is interest-free throughout those three months.
S$100,000 × 2.6% × 1/12 ≈ S$216.67 per month
The monthly figure is rounded for display. Using the unrounded monthly amounts, the illustrative total for the three months is S$650. If the director repays part of the loan during the quarter, use the actual month-end balance for each month. For a subsidised loan, deduct the interest payable by the director from the gross amount computed using the IRAS rate.
This example shows only the arithmetic. The S$650 benefit arises in income year 2026 and ordinarily belongs to YA 2027. It does not follow the company’s financial year end.
How the employer reports the 2026 benefit
IRAS treats taxable loan interest benefits as benefits-in-kind. For income year 2026, the employer records the amount at Appendix 8A item 4b and carries the total value of benefits-in-kind to Form IR8A item d8.
An employer in the Auto-Inclusion Scheme submits the 2026 employment-income information electronically to IRAS by 1 March 2027 and need not issue hardcopy Form IR8A or Appendix 8A. A non-AIS employer provides the completed hardcopy Form IR8A and the applicable appendix to the employee by 1 March 2027; it does not send those forms to IRAS unless requested.
Check the employer’s AIS status before acting. Tax-clearance requirements, including any Form IR21 question, remain outside this article.
Records to keep together
A workable director-loan file should allow the accountant or tax reviewer to reconstruct the balance and calculation without guessing. Keep:
- Loan terms: the signed loan agreement and drawdown record.
- Cash evidence: bank evidence for funds advanced and repayments received.
- Monthly balance: a schedule showing each month-end outstanding balance.
- Interest: the contractual rate, if any, and interest actually paid.
- Tax calculation: the IRAS rate used for each period and the monthly benefit calculation.
- Reporting: the Appendix 8A / Form IR8A working and the AIS or non-AIS submission record.
Keep any corporate approval or conflict record required for the transaction in the same matter file, but treat that as a separate company-law review. The tax calculation does not make an otherwise unauthorised loan permissible.
What to check before year end
Reconcile the director-loan ledger against the bank and repayment records. Confirm whether the balance shown is a genuine loan, a reimbursement, remuneration, a dividend or another transaction; the label in the ledger is not enough.
Then calculate the interest benefit month by month using the applicable IRAS rate, deducting the director’s interest payable for a subsidised loan. If any principal was waived, record the date and amount separately before completing the employment-income submission.
Frequently asked questions
Does the 2.6% rate mean the company must charge 2.6% interest?
No. The IRAS table provides a rate for computing the taxable interest benefit. It does not set a commercial lending rate or authorise the company to make the loan.
Can the company use 2.6% for every month of 2026?
No. The IRAS table shows 3.0% for January–March 2026 and 2.6% for April–December 2026. Use the rate that applies to each month.
What if the director repays part of the loan?
Use the actual outstanding balance at the end of each month in the monthly computation.
What if the director is also a shareholder?
Do not assume the loan falls outside the director rule. IRAS says shareholder capacity is a question of fact. A conclusion that the loan was made solely in shareholder capacity requires evidence and case-specific advice.
What if the company forgives the principal?
IRAS states that an amount of principal waived is taxable. Review the waiver separately from the interest benefit and keep evidence of the approval, date and amount.
Does this article confirm that the company may grant the loan?
No. Company-law authority, approvals and conflict procedures are outside this tax guide and should be checked before funds move.
Which YA covers the October–December 2026 benefit?
It arises in income year 2026 and ordinarily belongs to YA 2027. A benefit arising from January to March 2027 ordinarily belongs to YA 2028, even though IRAS currently lists the same 2.6% rate for both periods.
Official source and information boundary
- IRAS — Benefits Relating to Loans, last updated 23 September 2026; accessed 5 October 2026.
- IRAS — Income Tax: Benefits to Company Directors from Interest-Free/Subsidised Loans, third edition published 30 January 2026; accessed 5 October 2026.
- IRAS — Reporting Employee Earnings, last updated 10 August 2026; accessed 5 October 2026.
This article provides general information on the IRAS employment-tax treatment of loan benefits. It is not legal, tax or accounting advice for a particular company or director.
Reconcile the director-loan balance before tax reporting
If your year-end accounts include an amount due from a director, reconcile the balance and monthly movements first. ProSec can assist with the accounting schedule and coordinate a review of the general tax treatment; company-law permission and approvals require a separate check.
Review accounting and tax support